Latest Conference

Cultural differences between patients and physician are hard to avoid. How can you best work with diverse patients?

Transgender youth are at increased risk for a number of psychiatric morbidities. Gender identity conversion therapy can make them worse.

Sheldon Preskorn, MD, shares insights into drug mechanisms and delivery to better help patients with major depressive disorder.

Phase 3 results on MDMA-assisted therapy look promising for the treatment of PTSD. What other disorders can psychedelics help treat?

Sidney Zisook, MD, shares insights into defining depression diagnosis.

Chronic adolescent exposure to THC and cannabis could lead to adverse mental health outcomes and impacted brain functioning.

Health care workers have always been prone to stress and burnout, and the COVID-19 pandemic exacerbated the issue. What do we know about burnout and how can we prevent and address it?

Bringing science to the practice of psychiatry has been the personal goal of Sheldon H. Preskorn, MD—the Educator of the Year.

The pandemic caused the shut down of schools and resulted in virtual learning for most of the world's children and adolescents. How did they fare?

The National Correctional Health Care Conference is back and ready to deliver the latest on correctional and public health.

The 2021 American Psychiatric Association Virtual Annual Meeting brought together leaders in psychiatry to discuss hot topics including diversity, COVID-19, mood disorders, and more.

New research find altered states of consciousness may allow veterans and other patients with PTSD to face unspeakable experiences and find peace.

Joshua A. Gordon, MD, PhD, National Institute of Mental Health Director, leverages lessons from past natural disasters and traumas to foster resiliency and inform future research endeavors.

John J. Miller, MD, formally invites you to the Annual Psychiatric Times® World CME Conference™.

In his William C. Menninger Memorial Lecture, Anthony S. Fauci, MD, shared lessons learned and remaining challenges for the COVID-19 pandemic, especially in terms of mental health and behavioral issues.

What is excited delirium syndrome and how should it be treated? The short answer is we do not know.

Finding a program that is a good fit while LGBTQ+ may be more difficult than it seems…

Young, professional women in academic psychiatry are facing down the iceberg: gender discrimination.

What treatments could handle both psychiatric emergencies and long-standings mental health conditions—in a hurry?

Too often, the medical issues associated with traumatic brain injury are mistakenly diagnosed as psychiatric disorders. A few simple questions and tests can elucidate the real culprit and lead to appropriate treatment.

Collaborative care guides care across disciplines, including psychology, psychiatry, and primary care. The goal is to change practice, build community, and identify health professionals needing the most assistance.

According to Nora D. Volkow, MD, Director of the National Institute on Drug Abuse, drug use and overdose deaths have significantly increased since the outset of the pandemic. What made it worse?

What’s a psychiatrist to do? An APA ethics panel at the Annual Meeting considered various dilemmas, including possible conflicts between physicians’ obligations to individual patients and their obligation to promote the public good.

Can depression be passed on to future generations, and if it can, how can treatment help?

One doctor at the APA Virtual meeting explains how ketamine can rebuild spine and synaptic proteins in the brain, but may be difficult to actually prescribe to patients.

Timothy W. Fong, MD, touches on our current understanding about cannabis use for psychiatric disorders.

The last year has seen an unprecedented shift in the medical landscape, and mental health care is no exception. Experts look at the evidence and risks of digital tools, apps, telehealth, and other technologies for the treatment of serious mental illness.

Obsessive-compulsive disorder and related conditions do not always respond to first-line treatments. Fortunately, new options are on the horizon.